Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
about
Focus on renal congestion in heart failureHepato-cardiac disordersLeft ventricular assist devices as a bridge to cardiac transplantation.Mechanical Circulatory Support and the Role of LVADs in Heart Failure Therapy.The Total Artificial Heart in End-Stage Congenital Heart DiseasePrevalence and prognostic importance of changes in renal function after mechanical circulatory supportEarly adverse events as predictors of 1-year mortality during mechanical circulatory support.A patient with heart failure and worsening kidney functionPhysiological impact of continuous flow on end-organ function: clinical implications in the current era of left ventricular assist devices.Long-term continuous-flow left ventricular assist devices (LVAD) as bridge to heart transplantationAcute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devicesIncidence and predictors of cognitive decline in patients with left ventricular assist devices.Left ventricular assist devices: a kidney's perspective.Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantationDurable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomesMagnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.HeartMate® II continuous-flow left ventricular assist system.State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy.The pharmacotherapy implications of ventricular assist device in the patient with end-stage heart failure.Mechanical circulatory support: devices, outcomes and complications.Patient selection for mechanical circulatory support.Left ventricular assist devices in heart failure.Cardiorenal syndrome: pathophysiology and potential targets for clinical management.Co-morbidities in heart failure.Rotary blood pumps as definitive treatment for severe heart failure.Physiologic and hematologic concerns of rotary blood pumps: what needs to be improved?Interactions of the heart and the liver.Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.B-type natriuretic peptide trends after pediatric heart transplantation.Current status of extracorporeal ventricular assist devices in Japan.Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?Mechanical circulatory support devices: methods to optimize hemodynamics during use.Is Implantation of a Left Ventricular Assist Device in Patients With Critical or Impending Cardiogenic Shock an Absolute Contraindication? Looking Back at Our Past Experience Trying to Identify Contraindicative Risk Factors.Use of the model for end-stage liver disease score for guiding clinical decision-making in the selection of patients for emergency cardiac transplantation.Successful organ donation after long-term circulatory support with nonpulsatile mechanical support.Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.Left Ventricular Assist Devices and the Kidney.[Indications and strategies in mechanical circulatory support : Rise of the machines?]
P2860
Q26769905-80C41CA7-781E-49A9-8970-A6B94C938214Q26997114-09608BE6-200B-4AB3-88F8-304507A33469Q26999337-600146C5-374E-438D-AD95-B4142A2AE8ABQ27690750-BF1E0A5D-FA51-42DE-90F6-B4D54A8BF3C4Q33650322-9037127B-D836-402B-808F-49B7862E229BQ33793204-62A3B060-E93E-44DD-BE05-5B087991FB75Q34079591-32DBB8C1-0E5D-4D48-966D-DC3B8831B135Q34292920-26E0E86A-ABF0-4973-AA24-E63D7494D486Q35183392-8FA9F4F1-7976-490B-AC68-5F0B1B598998Q35290569-2205043F-C5F7-440C-B913-7E92FC756F2EQ35559442-98ADE12D-9349-4085-BF2B-E6A41E53D15DQ35564908-EED841C0-5DF2-41F9-9493-5076DEC1F320Q35726089-595B2F0D-CC9B-4F81-B1CE-FAFE167D199AQ36116040-2024EA0F-56C7-467B-A620-999D21C0E9E9Q36351282-C9E0DFDE-F2D3-4F84-A63A-A3F5ED5864E1Q36686934-08D9F4FF-6E6C-4D27-9FF9-9878125684C8Q36776529-0D85A997-BAE8-49BC-82B1-280CDACE4835Q37286036-E04BFBC7-4AEE-4EBF-9256-144A2F4E7F64Q37820972-9A7FE4B8-3552-477E-B48F-B055ECF0A4DFQ37960332-D657D996-5A54-42DB-B6CA-ED2744E4058CQ37990893-C2005469-EB48-4F44-BDEB-8B23B1797292Q37991198-60AC3741-D651-4241-A728-CA1160D645B3Q38006419-D421A5FD-F4AF-4521-8430-A3845E18AA28Q38014982-2D433161-6FFF-41F8-96B7-19D062F7E3ABQ38068097-76FE114F-5266-411D-ACC9-3444C36F104EQ38069787-42243DCB-CA0A-4D1B-8691-C399762B77D5Q38086842-4C60514A-E19C-4804-9741-C1EAAD6559CAQ38095401-E7054D9A-FCC4-4CEB-A600-22A69ABC8CCBQ38121525-A206A557-B114-4C0C-A369-527E8C8DA967Q38167670-475AAABE-CD92-483B-A7E9-851BCF87D586Q38219702-D07BB480-BB70-421A-8E01-FB4276BA8BFEQ38222193-C09BE21E-77E2-4B9F-A8EC-D20732806E10Q38262776-C89E4B62-89FE-45FA-9F89-866AD826ED8FQ38690293-7E91F62B-64E6-4EF6-B565-E664F43A6FC1Q41717266-FEFC82A6-A35D-4EAE-8F32-06D11B9EB1FBQ44617936-0F0E737A-E2BE-4FD5-9563-BDBA12C62240Q46569507-9BDDFBB2-08C8-462B-8759-BF6F4DA5CAFBQ47446628-A277AAAB-A20B-4C64-AA90-A5D648E09D5AQ47718161-9A6033AD-66BC-4AE4-A7A2-5A8ADC2A431AQ50490210-EC8D3148-F14D-47BE-B916-3BA37C030BE6
P2860
Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Renal and hepatic function imp ...... eft ventricular assist device.
@en
Renal and hepatic function imp ...... eft ventricular assist device.
@nl
type
label
Renal and hepatic function imp ...... eft ventricular assist device.
@en
Renal and hepatic function imp ...... eft ventricular assist device.
@nl
prefLabel
Renal and hepatic function imp ...... eft ventricular assist device.
@en
Renal and hepatic function imp ...... eft ventricular assist device.
@nl
P2093
P1433
P1476
Renal and hepatic function imp ...... left ventricular assist device
@en
P2093
Andrew J Boyle
Carmelo A Milano
Charles T Klodell
David B Dyke
David J Farrar
H Todd Massey
HeartMate II Clinical Investigators
John V Conte
Joseph G Rogers
Juan M Aranda
P304
P356
10.1161/CIRCULATIONAHA.108.814863
P407
P577
2009-11-23T00:00:00Z